RxDoctor Payments Data

Subita Mangru

Adolescent Medicine · Millburn, NJNPI 1043279193

Payments from drug & device makers

What this record shows

18 manufacturers reported payments, led by Pfizer at 57.9% of the total. Reporting peaked in 2020 at $1,681 and has fallen 74.7% since, to $425 in 2025. Among adolescent medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,959in general payments, 2019–2025

Across 96 payments — averaging $30.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Merck$299
  • Sanofi Pasteur Inc.$242
  • Kaleo, Inc.$191
  • Sobi, Inc$100
  • Alk-abello, Inc$70
  • plus $346 from 12 others

What the payments were for

  • Speaking & faculty fees$1,50051%
  • Food & beverage$1,45949%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,959 in reported general payments places this provider in the 90th percentile of 156 adolescent medicine providers in New Jersey.

See all adolescent medicine providers in New Jersey

Other adolescent medicine in Millburn

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →